Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proliverenol for NAFLD
NCT06127225Phase 2Completed
- Sponsor
- Dexa Medica
- Start
- Apr 2023
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Proliverenol in non-alcoholic fatty liver disease (NAFLD), sponsored by Dexa Medica. Started Apr 2023; status: completed.
02
Drugs
Proliverenol
03
Conditions
non-alcoholic fatty liver disease (NAFLD)
Beyond the preview
Go deeper on NCT06127225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06127225.